Intuitive Surgical delivered robust fourth-quarter 2025 results, with adjusted earnings per share of $2.53, exceeding Zacks Consensus estimates by 12.4%, and total revenues of $2.87 billion, beating expectations by 4.7%. The company reported an approximate 18% growth in da Vinci procedures, bringing global totals to over 3.1 million, and recurring revenues increased by 20%, accounting for 81% of fourth-quarter sales. Looking forward, Intuitive Surgical projects a 13-15% growth in procedures for 2026, bolstered by innovations in robotic surgery.
“Intuitive Surgical · has been a leader in · robotic surgical systems · annual gains of 19% over the past 15 years”
“Intuitive Surgical · had · da Vinci procedures · more than 3.1 million globally in 2025”
“Intuitive Surgical · saw · da Vinci procedures growth · approximately 18%”
“Intuitive Surgical · experienced · total revenues increase · 21%”
“Intuitive Surgical · experienced · recurring revenues growth · 20%”
“Intuitive Surgical · recurring revenues represented · sales in the fourth quarter · 81%”
“Intuitive Surgical · had · installed base of robotic systems · more than 11,100 systems”
“Intuitive Surgical · expanded · da Vinci installed base · 12%”
“Intuitive Surgical · placed · da Vinci systems in 2025 · 1,721”
“Intuitive Surgical · projected · procedure growth guidance · 13-15%”
“Intuitive Surgical · currently trades at · P/E ratio · 49.41”
“Intuitive Surgical · holds a Zacks Rank · #1 (Strong Buy)”